IGC Pharma IGC
NYSE IGC
$0.25 +0.00 (+0.20%)
As of: Oct 21, 2026 · 3:54 PM EDT

IGC Pharma (IGC) Other Non-Current Assets (2011 - 2026)

Updated

IGC Pharma (IGC) recorded Other Non-Current Assets of $659,000 in Q4 2026, down 3.2% from $681,000 a year earlier and down 1.5% from the prior quarter.

Analysis

IGC Pharma (IGC) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Starting with Q4 2011, IGC Pharma's Other Non-Current Assets history includes 61 quarters.

  • Annual Other Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 1.8% (FY2021 to FY2026).
  • Across earlier years, Other Non-Current Assets came in at $681,000 in FY2025 (-1.0%), $688,000 in FY2024 (-31.4%), $1 million in FY2023 (+7.0%) and $937,000 in FY2022 (+55.4%).
  • The Q4 2026 figure is the lowest quarterly Other Non-Current Assets since Q3 2022.
  • On a year-over-year basis, Other Non-Current Assets has declined for ten consecutive quarters, with an average decline of 13.1% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 68.0% in Q3 2023, against a decline of 32.4% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $669,000 (Q3 2026), $672,000 (Q2 2026) and $680,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 IGC Pharma 24.10 Mn 21.34 Mn 55,000.00 659,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 659,000.00
Dec 31, 2025 669,000.00
Sep 30, 2025 672,000.00
Jun 30, 2025 680,000.00
Mar 31, 2025 681,000.00
Dec 31, 2024 681,000.00
Sep 30, 2024 687,000.00
Jun 30, 2024 688,000.00
Mar 31, 2024 688,000.00
Dec 31, 2023 999,000.00
Sep 30, 2023 998,000.00
Jun 30, 2023 1.02 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 950,000.00
Jun 30, 2022 922,000.00
Mar 31, 2022 937,000.00
Dec 31, 2021 612,000.00
Sep 30, 2021 611,000.00
Jun 30, 2021 596,000.00
API Access

IGC Pharma Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IGC&period=max&api_key=YOUR_API_KEY